logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Frontiers in Oncology cover

Frontiers in Oncology

IF3.3
Papers35086
Citations94533
Journal Papers 34999
Publication Date
delete
FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteDA Diyaer Abuduaini †; DS Diernu Simayi †; MM Mihelayi Maimaiti; YF Yinglan Feng; YW Yixia Wang
deleteShare
deleteSave
Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteMT Mian T. Mhindu; SL Stacia L. Koppenhafer; MG Mason G. Lyons; JA Jessica A.O. Zimmerman; DJ David J. Gordon
deleteShare
deleteSave
FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteGO Ghaleb Oriquat; HM Hani Moslem Ahmed; JR Jasur Rizaev; MK Mamura Kucharova; DP Djamila Polatova; MA Mrtda Adnan Mhysn; NK Navin Kumar Tailor
deleteShare
deleteSave
Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteYZ Yihui Zhang; ND Ning Ding; YC Yingchao Cui; CY Changlin Yi; WC Wenkai Chen
deleteShare
deleteSave
Integrating overall survival and health-related quality of life to prioritize first-line systemic therapies for unresectable advanced gastric cancer: a network meta-analysis
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteJW Ji Wu †; ZZ Zhigang Zheng †; XS Xiping Shen; HD Huijuan Dai; YW Yefeng Wu
deleteShare
deleteSave
Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteXW Xingwei Wang; ZZ Ziyue Zhang; MC Mei Chen; LL Liu Luo; RS Ru Sun; CC Chen Chen; MY Minmin Yu
deleteShare
deleteSave
Prediction of pathological complete response after neoadjuvant therapy in breast cancer using pretreatment core biopsy pathology reports: a pathology-report-driven model with exploratory clinical-laboratory fusion
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteRZ Rui Zhang; LQ Luxia Qi; BL Bin Li; GZ Guifang Zhang
deleteShare
deleteSave
Reduced graphene oxide-incorporated gelatin-oxidized polymannose scaffold-based 3D Lung cancer model for mimicking the tumor microenvironment
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteHP Hema Priya Manivannan; VP Vishnu Priya Veeraraghavan; KP K. P. Ameya; DS Durairaj Sekar; AP Arul Prakash Francis †
deleteShare
deleteSave
Number of examined lymph nodes and overall survival in intrahepatic cholangiocarcinoma: a population-based study suggesting a staging benefit
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteXH Xuchang He †; WA Wenhui An †; YC Yangwei Chen; SW Shuang Wang; YH Yan He; EL En Luo
deleteShare
deleteSave
Prostatic malakoplakia: a rare case report and literature review
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteYW Yuanhao Wang; GM Gang Mu
deleteShare
deleteSave
Correction: Unlocking the potential of immunotherapy for patients with resectable non–small cell lung cancer
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteSP Sandip Pravin Patel; JG Justin Gainor; SK Steven Kao; SL Se-Hoon Lee; TM Tony Mok; RS Riyaz Shah; CZ Caicun Zhou; SP Solange Peters
deleteShare
deleteSave
Tumor-associated macrophages beyond M1/M2 in NSCLC: spatially organized programs, therapy resistance, and translational targeting
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteXW Xiao-Long Wang; ZJ Ziheng Jiang; QL Qianqian Lu; MF Min Fang
deleteShare
deleteSave
Case Report: Site-specific therapy guided by the 90-gene expression assay in cancer of unknown primary: lenvatinib plus camrelizumab for occult renal cell carcinoma
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteLD Liangshan Da; TM Tai Ma; JD Jie Da; WP Wanren Peng
deleteShare
deleteSave
Case Report: Simultaneous stereotactic re-irradiation using HyperArc for 44 brain metastases after whole-brain radiotherapy
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteMR Maximilian Römer; PB Peter Bublak; IM Irina Mäurer; PF Philipp Franke; SD Sonia Drozdz; GW Georg Wurschi; NM Noreen Murr; KP Klaus Pietschmann; MM Matthias Mäurer
deleteShare
deleteSave
Clinical outcomes and prognostic factors of Ommaya reservoir-based intrathecal chemotherapy in lung cancer leptomeningeal metastasis: a retrospective cohort study
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteYY Yuechao Yang †; MF Mingtao Feng †; YX Yu Xuan Ong †; ZQ Zhe Qi; BP Bihani Pokharel; LZ Lushao Zhang; KW Kexuan Wang; JC Jiatong Chen; CZ Changshuai Zhou; LC Lei Chen; DL Deheng Li; ZH Zhihuang Hu; LL Liangdong Li; YC Yiqun Cao; YG Yang Gao
deleteShare
deleteSave
Recurrent thymoma-associated PRCA with persistent agranulocytosis: a case report and therapeutic considerations
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteAW Antuo Wang †; YX Yu Xia †; MX Mengyuan Xin †; LS Liang Song; BJ Bin Jiang; MS Mo Shi; ZX Zhongwei Xin
deleteShare
deleteSave
Real-world clinical outcomes and safety of anlotinib-containing regimens in pediatric solid tumors: a retrospective cohort study at a Chinese center
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteQH Qiaoli Hua; ZX Zhouqi Xia; YG Yaqing Gu; JW Jinhu Wang; SN Shaoqing Ni
deleteShare
deleteSave
Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteJL Jia-Le Li; PW Pei-Tao Wu; JS Jing-Shuang Song; HY Hua-Wei Yang
deleteShare
deleteSave
Clinical diagnostic value of serum CEA and CA19–9 in patients with advanced pancreatic cancer: A prognostic cohort study
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteJS Jianjun Song †; FK Fuping Kang †; LM Lan Ma †; AZ Aidi Zhang; FY Fangfang Yang; QL Qing Liu
deleteShare
deleteSave
Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis
deleteFrontiers in Oncology
IF3.3
delete2026-09-29
delete0
deleteOAAI
deleteCH Chunle Hu; LZ Li Zhan; YL Yanhui Li; XR Xiawei Ren; ZY Zhiyong Yu
deleteShare
deleteSave